Latest filing published 09 Nov 2021 for Inotiv, Inc..
Insider track record
No signal scores available.
Mark L. Bibi: trading record in brief
Filings by Mark L. Bibi span 2 companies, the busiest being Life Sciences Research Inc and Inotiv, Inc. We count 5 filings; the first trade dates from 10 April 2006 and the latest from 5 November 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 9 November 2021, the filings show a share grant in Inotiv, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark L. Bibi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 58,134 sharesCommon SharesSEC:0001179110-21-010015:0
- 35,700 shares0Voting Common Stock, par value $.01 per shareSEC:0001158833-08-000036:0
- 35,700 shares0Voting Common Stock, par value $.01 per shareSEC:0001158833-08-000036:1
- 50,000 sharesVoting Common Stock, par value $.01 per shareSEC:0001158833-06-000054:0
- 8,152 shares@ US$9.20Voting Common Stock, par value $.01 per shareSEC:0001158833-06-000017:0
5 of 5 declarations
